Supplementary Tables – The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial data
dataset
posted on 2022-06-15, 09:06 authored by Taylor & FrancisTaylor & Francis, Satoru Iwasa, Hideaki Bando, Yongzhe Piao, Kenichi Yoshizawa, Kensei Yamaguchi
Supplementary Table 1. Overview of targeted therapeutics approved for advanced gastric cancer
Supplementary Table 2: Published real-world studies on ramucirumab-containing regimens in AGC
Supplementary Table 3. Published clinical studies on ramucirumab-containing regimens in AGC in the first-line setting
Supplementary Table 4. Published clinical studies on ramucirumab-containing regimens in AGC in the third-line and perioperative settings
Supplementary Table 5. New and ongoing studies on ramucirumab in advanced gastric cancer (NCT and jRCT databases)
